These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25688146)

  • 21. The association of myocardial infarction process of care measures and in-hospital mortality: a report from the NCDR®.
    Kontos MC; Rennyson SL; Chen AY; Alexander KP; Peterson ED; Roe MT
    Am Heart J; 2014 Nov; 168(5):766-75. PubMed ID: 25440806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative.
    Bangalore S; Messerli FH; Ou FS; Tamis-Holland J; Palazzo A; Roe MT; Hong MK; Peterson ED;
    Am Heart J; 2009 Mar; 157(3):525-31. PubMed ID: 19249424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pay for performance, quality of care, and outcomes in acute myocardial infarction.
    Glickman SW; Ou FS; DeLong ER; Roe MT; Lytle BL; Mulgund J; Rumsfeld JS; Gibler WB; Ohman EM; Schulman KA; Peterson ED
    JAMA; 2007 Jun; 297(21):2373-80. PubMed ID: 17551130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE).
    Alexander D; Ou FS; Roe MT; Pollack CV; Ohman EM; Cannon CP; Gibler WB; Fintel DJ; Peterson ED; Brown DL;
    Am Heart J; 2008 Sep; 156(3):606-12. PubMed ID: 18760147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.
    Diercks DB; Roe MT; Mulgund J; Pollack CV; Kirk JD; Gibler WB; Ohman EM; Smith SC; Boden WE; Peterson ED
    Am Heart J; 2006 Jul; 152(1):140-8. PubMed ID: 16824844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.
    Spinler SA; Ou FS; Roe MT; Gibler WB; Ohman EM; Pollack CV; Alexander KP; Peterson ED
    Pharmacotherapy; 2009 Jun; 29(6):631-8. PubMed ID: 19476416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies.
    Lefebvre CW; Hoekstra J
    Hosp Pract (1995); 2010 Apr; 38(2):40-9. PubMed ID: 20469612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of transfer-in rates on quality of care and outcomes at receiving hospitals in patients with non-ST-segment elevation myocardial infarction.
    Mehta RH; Chen AY; Ohman EM; Gibler WB; Peterson ED; Roe MT;
    Am Heart J; 2010 Sep; 160(3):405-11. PubMed ID: 20826246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Better outcomes for patients treated at hospitals that participate in clinical trials.
    Majumdar SR; Roe MT; Peterson ED; Chen AY; Gibler WB; Armstrong PW
    Arch Intern Med; 2008 Mar; 168(6):657-62. PubMed ID: 18362259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative.
    Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT
    Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance metrics as drivers of quality: getting to second gear.
    Lee TH
    Circulation; 2015 Mar; 131(11):967-8. PubMed ID: 25688145
    [No Abstract]   [Full Text] [Related]  

  • 32. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
    Banihashemi B; Goodman SG; Yan RT; Welsh RC; Mehta SR; Montalescot G; Kornder JM; Wong GC; Gyenes G; Steg PG; Yan AT;
    Am Heart J; 2009 Dec; 158(6):917-24. PubMed ID: 19958857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.
    Blomkalns AL; Chen AY; Hochman JS; Peterson ED; Trynosky K; Diercks DB; Brogan GX; Boden WE; Roe MT; Ohman EM; Gibler WB; Newby LK;
    J Am Coll Cardiol; 2005 Mar; 45(6):832-7. PubMed ID: 15766815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achievement of guideline-concordant care and in-hospital outcomes in patients with coronary artery disease in teaching and nonteaching hospitals: results from the Get With The Guidelines-Coronary Artery Disease program.
    Tam LM; Fonarow GC; Bhatt DL; Grau-Sepulveda MV; Hernandez AF; Peterson ED; Schwamm LH; Giugliano RP;
    Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):58-65. PubMed ID: 23233750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
    Wang TY; Ou FS; Roe MT; Harrington RA; Ohman EM; Gibler WB; Peterson ED
    Circulation; 2009 May; 119(18):2454-62. PubMed ID: 19398666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
    Brogan GX; Peterson ED; Mulgund J; Bhatt DL; Ohman EM; Gibler WB; Pollack CV; Farkouh ME; Roe MT
    Diabetes Care; 2006 Jan; 29(1):9-14. PubMed ID: 16373888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes.
    Roe MT; Chen AY; Mehta RH; Li Y; Brindis RG; Smith SC; Rumsfeld JS; Gibler WB; Ohman EM; Peterson ED
    Circulation; 2007 Sep; 116(10):1153-61. PubMed ID: 17709638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual quality improvement in acute coronary syndromes: a performance improvement initiative.
    Cannon CP; Hoekstra JW; Larson DM; Mencia WA; Cornish J; Carter RD; Berry CA; Karcher RB
    Crit Pathw Cardiol; 2009 Mar; 8(1):43-8. PubMed ID: 19258838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modest Associations Between Electronic Health Record Use and Acute Myocardial Infarction Quality of Care and Outcomes: Results From the National Cardiovascular Data Registry.
    Enriquez JR; de Lemos JA; Parikh SV; Simon DN; Thomas LE; Wang TY; Chan PS; Spertus JA; Das SR
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):576-85. PubMed ID: 26487739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes.
    LaPointe NM; Chen AY; Alexander KP; Roe MT; Pollack CV; Lytle BL; Ohman ME; Gibler BW; Peterson ED
    Arch Intern Med; 2007 Jul; 167(14):1539-44. PubMed ID: 17646609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.